US443459A
(en)
|
|
1890-12-23 |
|
Clarence l |
FR640907A
(fr)
|
1927-06-25 |
1928-07-24 |
|
Limitateur de débit automatique
|
US2168437A
(en)
|
1935-04-10 |
1939-08-08 |
Kenneth O Buercklin |
Injection device
|
US2133073A
(en)
|
1935-12-30 |
1938-10-11 |
Manning Maxwell & Moore Inc |
Method of and apparatus for controlling pressure fluid
|
US2110208A
(en)
|
1937-02-12 |
1938-03-08 |
U S Standard Products Company |
Antigen preparations
|
US2531724A
(en)
|
1948-09-20 |
1950-11-28 |
Edmund D Cevasco |
Infant bath mat
|
US3025991A
(en)
|
1960-05-23 |
1962-03-20 |
Carron Products Co |
Bottle stopper
|
BE634668A
(ru)
|
1962-07-11 |
|
|
|
GB1049104A
(en)
|
1963-05-11 |
1966-11-23 |
Prodotti Antibiotici Spa |
Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
|
US3122162A
(en)
|
1963-06-20 |
1964-02-25 |
Asa D Sands |
Flow control device
|
BE744162A
(fr)
|
1969-01-16 |
1970-06-15 |
Fuji Photo Film Co Ltd |
Procede d'encapsulage
|
US3632768A
(en)
|
1969-10-02 |
1972-01-04 |
Upjohn Co |
Therapeutic composition and method for treating infections with actinospectacin
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
US3713919A
(en)
|
1970-08-17 |
1973-01-30 |
Du Pont |
Chemical foaming of water-bearing explosives with n,n'-dimitrosopentamethylene-tetramine
|
US3732865A
(en)
|
1971-01-13 |
1973-05-15 |
Alza Corp |
Osmotic dispenser
|
US3995631A
(en)
|
1971-01-13 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US4211771A
(en)
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
JPS523342B2
(ru)
|
1972-01-26 |
1977-01-27 |
|
|
BE795516A
(fr)
|
1972-02-17 |
1973-08-16 |
Ciba Geigy |
Preparations de peptides huileuses et injectables et procede pour leur preparation
|
US3797492A
(en)
|
1972-12-27 |
1974-03-19 |
Alza Corp |
Device for dispensing product with directional guidance member
|
US3995632A
(en)
|
1973-05-04 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser
|
GB1413186A
(en)
|
1973-06-27 |
1975-11-12 |
Toyo Jozo Kk |
Process for encapsulation of medicaments
|
DE2528516A1
(de)
|
1974-07-05 |
1976-01-22 |
Sandoz Ag |
Neue galenische zubereitung
|
JPS523653A
(en)
|
1975-06-27 |
1977-01-12 |
Fuji Photo Film Co Ltd |
Process for producing fine polymer particles
|
US3987790A
(en)
|
1975-10-01 |
1976-10-26 |
Alza Corporation |
Osmotically driven fluid dispenser
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4078060A
(en)
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
US4111202A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
US4203439A
(en)
|
1976-11-22 |
1980-05-20 |
Alza Corporation |
Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
USD258837S
(en)
|
1977-10-17 |
1981-04-07 |
Gambro Dialysatoren Gmbh And Co. Kg |
Dialyzer cartridge
|
USD259458S
(en)
|
1978-06-09 |
1981-06-09 |
Fuller Charles R |
Support pad for an infant
|
US4243030A
(en)
|
1978-08-18 |
1981-01-06 |
Massachusetts Institute Of Technology |
Implantable programmed microinfusion apparatus
|
US4305927A
(en)
|
1979-02-05 |
1981-12-15 |
Alza Corporation |
Method for the management of intraocular pressure
|
US4373527B1
(en)
|
1979-04-27 |
1995-06-27 |
Univ Johns Hopkins |
Implantable programmable medication infusion system
|
US4310516A
(en)
|
1980-02-01 |
1982-01-12 |
Block Drug Company Inc. |
Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
|
US4384975A
(en)
|
1980-06-13 |
1983-05-24 |
Sandoz, Inc. |
Process for preparation of microspheres
|
AU546785B2
(en)
|
1980-07-23 |
1985-09-19 |
Commonwealth Of Australia, The |
Open-loop controlled infusion of diabetics
|
US4350271A
(en)
|
1980-08-22 |
1982-09-21 |
Alza Corporation |
Water absorbing fluid dispenser
|
US4376118A
(en)
|
1980-10-06 |
1983-03-08 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
US4340054A
(en)
|
1980-12-29 |
1982-07-20 |
Alza Corporation |
Dispenser for delivering fluids and solids
|
US4444498A
(en)
|
1981-02-27 |
1984-04-24 |
Bentley Laboratories |
Apparatus and method for measuring blood oxygen saturation
|
US4455145A
(en)
|
1981-07-10 |
1984-06-19 |
Alza Corporation |
Dispensing device with internal drive
|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
EP0079143A3
(en)
|
1981-10-20 |
1984-11-21 |
Adnovum Ag |
Pseudoplastic gel transfer
|
DE3273597D1
(en)
|
1981-11-28 |
1986-11-06 |
Sunstar Kk |
Pharmaceutical composition containing interferon in stable state
|
US5004689A
(en)
|
1982-02-22 |
1991-04-02 |
Biogen, Massachusetts |
DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4455143A
(en)
|
1982-03-22 |
1984-06-19 |
Alza Corporation |
Osmotic device for dispensing two different medications
|
US6936694B1
(en)
|
1982-05-06 |
2005-08-30 |
Intermune, Inc. |
Manufacture and expression of large structural genes
|
DE3220116A1
(de)
|
1982-05-28 |
1983-12-01 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4753651A
(en)
|
1982-08-30 |
1988-06-28 |
Alza Corporation |
Self-driven pump
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
US4552561A
(en)
|
1982-12-23 |
1985-11-12 |
Alza Corporation |
Body mounted pump housing and pump assembly employing the same
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
US4639244A
(en)
|
1983-05-03 |
1987-01-27 |
Nabil I. Rizk |
Implantable electrophoretic pump for ionic drugs and associated methods
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
DE3320583A1
(de)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
JPS6058915A
(ja)
|
1983-09-12 |
1985-04-05 |
Fujisawa Pharmaceut Co Ltd |
薬物含有脂質小胞体製剤
|
US4594108A
(en)
|
1983-09-19 |
1986-06-10 |
The Dow Chemical Company |
Highly pseudoplastic polymer solutions
|
US5385738A
(en)
|
1983-10-14 |
1995-01-31 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection
|
US4923805A
(en)
|
1983-11-02 |
1990-05-08 |
Integrated Genetics, Inc. |
Fsh
|
US5639639A
(en)
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
US4840896A
(en)
|
1983-11-02 |
1989-06-20 |
Integrated Genetics, Inc. |
Heteropolymeric protein
|
MX9203641A
(es)
|
1983-12-16 |
1992-07-01 |
Genentech Inc |
Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
|
US4855238A
(en)
|
1983-12-16 |
1989-08-08 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
US5231176A
(en)
|
1984-08-27 |
1993-07-27 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons
|
US5120832A
(en)
|
1984-08-27 |
1992-06-09 |
Genentech, Inc. |
Distinct family of human leukocyte interferons
|
US4927687A
(en)
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
US5411951A
(en)
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
FI90990C
(fi)
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
|
US4655462A
(en)
|
1985-01-07 |
1987-04-07 |
Peter J. Balsells |
Canted coiled spring and seal
|
JPS61189230A
(ja)
|
1985-02-19 |
1986-08-22 |
Nippon Kayaku Co Ltd |
エトポシド製剤
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4885166A
(en)
|
1985-06-11 |
1989-12-05 |
Ciba-Geigy Corporation |
Hybrid interferons
|
US4845196A
(en)
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
US4847079A
(en)
|
1985-07-29 |
1989-07-11 |
Schering Corporation |
Biologically stable interferon compositions comprising thimerosal
|
IE59361B1
(en)
|
1986-01-24 |
1994-02-09 |
Akzo Nv |
Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
|
DE3607835A1
(de)
|
1986-03-10 |
1987-09-24 |
Boehringer Ingelheim Int |
Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
|
US4865845A
(en)
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
US4737437A
(en)
|
1986-03-27 |
1988-04-12 |
East Shore Chemical Co. |
Light sensitive diazo compound, composition and method of making the composition
|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
US4755180A
(en)
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
DE3636123A1
(de)
|
1986-10-23 |
1988-05-05 |
Rentschler Arzneimittel |
Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
ZA878295B
(en)
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
JPS63145112A
(ja)
|
1986-12-09 |
1988-06-17 |
Honda Motor Co Ltd |
自動車のリヤサスペンシヨン装置
|
DE3642096A1
(de)
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
Pferde-(gamma)-interferon
|
US5371089A
(en)
|
1987-02-26 |
1994-12-06 |
Senetek, Plc |
Method and composition for ameliorating the adverse effects of aging
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
JPH0720866B2
(ja)
|
1987-05-15 |
1995-03-08 |
三生製薬株式会社 |
エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US4940465A
(en)
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US4874388A
(en)
|
1987-06-25 |
1989-10-17 |
Alza Corporation |
Multi-layer delivery system
|
US5938654A
(en)
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5023088A
(en)
|
1987-06-25 |
1991-06-11 |
Alza Corporation |
Multi-unit delivery system
|
US4915949A
(en)
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
ATE86484T1
(de)
|
1987-08-08 |
1993-03-15 |
Akzo Nv |
Kontrazeptives implantat.
|
US4915954A
(en)
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering a drug at two different rates
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
US4886668A
(en)
|
1987-09-24 |
1989-12-12 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic pump
|
GB8723846D0
(en)
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
AU2810189A
(en)
|
1987-10-30 |
1989-05-23 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
US4917895A
(en)
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4915366A
(en)
|
1988-04-25 |
1990-04-10 |
Peter J. Balsells |
Outside back angle canted coil spring
|
US4876781A
(en)
|
1988-04-25 |
1989-10-31 |
Peter J. Balsells |
Method of making a garter-type axially resilient coiled spring
|
US5117066A
(en)
|
1988-04-25 |
1992-05-26 |
Peter J. Balsells |
Retaining and locking electromagnetic gasket
|
US4961253A
(en)
|
1988-04-25 |
1990-10-09 |
Peter J. Balsells |
Manufacturing method for canted-coil spring with turn angle and seal
|
US4964204A
(en)
|
1988-04-25 |
1990-10-23 |
Peter J. Balsells |
Method for making a garter-type axially-resilient coil spring
|
US5108078A
(en)
|
1988-04-25 |
1992-04-28 |
Peter J. Balsells |
Canted-coil spring loaded while in a cavity
|
US4826144A
(en)
|
1988-04-25 |
1989-05-02 |
Peter J. Balsells |
Inside back angle canted coil spring
|
US4974821A
(en)
|
1988-04-25 |
1990-12-04 |
Peter J. Balsells |
Canted-coil spring with major axis radial loading
|
ATE94955T1
(de)
|
1988-04-25 |
1993-10-15 |
Peter J Balsells |
In sich geschlossene ringfoermige schraubenfeder mit aeusserem, rueckwaertigem neigungswinkel.
|
US4893795A
(en)
|
1988-08-15 |
1990-01-16 |
Peter J. Balsells |
Radially loaded canted coiled spring with turn angle
|
US4830344A
(en)
|
1988-04-25 |
1989-05-16 |
Peter J. Balsells |
Canted-coil spring with turn angle and seal
|
US5160122A
(en)
|
1990-03-20 |
1992-11-03 |
Peter J. Balsells |
Coil spring with an elastomer having a hollow coil cross section
|
US5203849A
(en)
|
1990-03-20 |
1993-04-20 |
Balsells Peter J |
Canted coil spring in length filled with an elastomer
|
US5079388A
(en)
|
1989-12-01 |
1992-01-07 |
Peter J. Balsells |
Gasket for sealing electromagnetic waves
|
US4934666A
(en)
|
1988-04-25 |
1990-06-19 |
Peter J. Balsells |
Coiled spring electromagnetic shielding gasket
|
US4907788A
(en)
|
1988-04-25 |
1990-03-13 |
Peter J. Balsells |
Dual concentric canted-coil spring apparatus
|
US5072070A
(en)
|
1989-12-01 |
1991-12-10 |
Peter J. Balsells |
Device for sealing electromagnetic waves
|
US5006346A
(en)
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5160743A
(en)
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US4931285A
(en)
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
JP2827287B2
(ja)
|
1988-07-05 |
1998-11-25 |
武田薬品工業株式会社 |
水溶性薬物含有徐放型マイクロカプセル
|
JP2794022B2
(ja)
|
1988-11-11 |
1998-09-03 |
三生製薬株式会社 |
ブナゾシン或いはその塩類含有経皮適用製剤
|
US5126141A
(en)
|
1988-11-16 |
1992-06-30 |
Mediventures Incorporated |
Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
|
US5728088A
(en)
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5059423A
(en)
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5110596A
(en)
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5057318A
(en)
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5234424A
(en)
|
1988-12-28 |
1993-08-10 |
Alza Corporation |
Osmotically driven syringe
|
US4969884A
(en)
|
1988-12-28 |
1990-11-13 |
Alza Corporation |
Osmotically driven syringe
|
US4976966A
(en)
|
1988-12-29 |
1990-12-11 |
Alza Corporation |
Delayed release osmotically driven fluid dispenser
|
IL92344A0
(en)
|
1989-01-04 |
1990-07-26 |
Gist Brocades Nv |
Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
|
US5288479A
(en)
|
1989-01-17 |
1994-02-22 |
Sterling Drug, Inc. |
Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
|
US5906816A
(en)
|
1995-03-16 |
1999-05-25 |
University Of Florida |
Method for treatment of autoimmune diseases
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
US5219572A
(en)
|
1989-03-17 |
1993-06-15 |
Pitman-Moore, Inc. |
Controlled release delivery device for macromolecular proteins
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
EP0432232B1
(en)
|
1989-05-01 |
1994-01-05 |
Alkermes Controlled Therapeutics, Inc. |
Process for producing small particles of biologically active molecules
|
AU5741590A
(en)
|
1989-05-04 |
1990-11-29 |
Southern Research Institute |
Improved encapsulation process and products therefrom
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5656207A
(en)
|
1989-06-24 |
1997-08-12 |
Gen Probe Incorporated |
Detecting or quantifying multiple analytes using labelling techniques
|
US5126142A
(en)
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5225205A
(en)
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
US5439688A
(en)
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
WO1991003510A1
(en)
|
1989-08-28 |
1991-03-21 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
US5112614A
(en)
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
US5290558A
(en)
|
1989-09-21 |
1994-03-01 |
Osteotech, Inc. |
Flowable demineralized bone powder composition and its use in bone repair
|
SE465950B
(sv)
|
1989-10-23 |
1991-11-25 |
Medinvent Sa |
Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
DE69003805T2
(de)
|
1989-11-13 |
1994-05-19 |
Becton Dickinson France |
Vorratsbehälter für einen bestandteil einer medikamentenlösung.
|
JPH03236317A
(ja)
|
1989-12-06 |
1991-10-22 |
Sansei Seiyaku Kk |
ドパミン誘導体含有経皮用製剤
|
US5540914A
(en)
|
1989-12-15 |
1996-07-30 |
The Board Of Regents Of The University Of Oklahoma |
Pigmentation enhancer and method
|
US5030216A
(en)
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
USD326718S
(en)
|
1989-12-26 |
1992-06-02 |
Minnesota Mining And Manufacturing Co. |
Blood sensor cassette
|
US5223266A
(en)
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5213809A
(en)
|
1990-01-24 |
1993-05-25 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
US5478564A
(en)
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
US5122128A
(en)
|
1990-03-15 |
1992-06-16 |
Alza Corporation |
Orifice insert for a ruminal bolus
|
US5120306A
(en)
|
1990-03-21 |
1992-06-09 |
Gosselin Leon F |
Direct delivery of anti-inflammatories to the proximal small bowel
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
US5213810A
(en)
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5290271A
(en)
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
US5374620A
(en)
|
1990-06-07 |
1994-12-20 |
Genentech, Inc. |
Growth-promoting composition and its use
|
US5234692A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234695A
(en)
|
1990-07-24 |
1993-08-10 |
Eastman Kodak Company |
Water dispersible vitamin E composition
|
USD329278S
(en)
|
1990-10-01 |
1992-09-08 |
Gallup Allen I |
Infant's bathing support
|
US5300302A
(en)
|
1990-10-04 |
1994-04-05 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
US5151093A
(en)
|
1990-10-29 |
1992-09-29 |
Alza Corporation |
Osmotically driven syringe with programmable agent delivery
|
US5122377A
(en)
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
IT1243390B
(it)
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
US5161806A
(en)
|
1990-12-17 |
1992-11-10 |
Peter J. Balsells |
Spring-loaded, hollow, elliptical ring seal
|
GB9027422D0
(en)
|
1990-12-18 |
1991-02-06 |
Scras |
Osmotically driven infusion device
|
WO1992011843A1
(en)
|
1991-01-09 |
1992-07-23 |
Alza Corporation |
Bioerodible devices and compositions for diffusional release of agents
|
NL9100160A
(nl)
|
1991-01-30 |
1992-08-17 |
Texas Instruments Holland |
Injector.
|
US5443459A
(en)
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5861166A
(en)
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
AU657973B2
(en)
|
1991-05-07 |
1995-03-30 |
Dynagen, Inc. |
A controlled, sustained release delivery system for smoking cessation
|
US5113938A
(en)
|
1991-05-07 |
1992-05-19 |
Clayton Charley H |
Whipstock
|
US5137727A
(en)
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
EP0520119A1
(de)
|
1991-06-17 |
1992-12-30 |
Spirig Ag Pharmazeutische Präparate |
Neue orale Diclofenaczubereitung
|
US5252338A
(en)
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5190765A
(en)
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
HU222501B1
(hu)
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
DE4122217C2
(de)
|
1991-07-04 |
1997-02-13 |
Merz & Co Gmbh & Co |
Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
|
US5288214A
(en)
|
1991-09-30 |
1994-02-22 |
Toshio Fukuda |
Micropump
|
YU87892A
(sh)
|
1991-10-01 |
1995-12-04 |
Eli Lilly And Company Lilly Corporate Center |
Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
|
EP0664118B1
(en)
|
1991-10-04 |
1999-08-25 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release tablet
|
WO1993006819A1
(en)
|
1991-10-10 |
1993-04-15 |
Alza Corporation |
Osmotic drug delivery devices with hydrophobic wall materials
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
US5318780A
(en)
|
1991-10-30 |
1994-06-07 |
Mediventures Inc. |
Medical uses of in situ formed gels
|
US5236707A
(en)
|
1991-11-08 |
1993-08-17 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
AU3136293A
(en)
|
1991-11-15 |
1993-06-15 |
Isp Investments Inc. |
Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
|
DE4137649C2
(de)
|
1991-11-15 |
1997-11-20 |
Gerhard Dingler |
Bauelement
|
US5213310A
(en)
|
1991-12-04 |
1993-05-25 |
Trli, Inc. |
Hydraulic release valve
|
US5200195A
(en)
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5223265A
(en)
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5658593A
(en)
|
1992-01-16 |
1997-08-19 |
Coletica |
Injectable compositions containing collagen microcapsules
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5456679A
(en)
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5209746A
(en)
|
1992-02-18 |
1993-05-11 |
Alza Corporation |
Osmotically driven delivery devices with pulsatile effect
|
US5308348A
(en)
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
ES2152248T3
(es)
|
1992-02-28 |
2001-02-01 |
Collagen Corp |
Composiciones de colageno de alta concentracion.
|
US5656297A
(en)
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
US5221278A
(en)
|
1992-03-12 |
1993-06-22 |
Alza Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
|
MX9301823A
(es)
|
1992-03-30 |
1994-01-31 |
Alza Corp |
Composicion para el suministro de liberacion controlado de un agente biologicamente activo.
|
AU3941793A
(en)
|
1992-03-30 |
1993-11-08 |
Alza Corporation |
Additives for bioerodible polymers to regulate degradation
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
FR2690622B1
(fr)
|
1992-04-29 |
1995-01-20 |
Chronotec |
Système de pompe à perfusion ambulatoire programmable.
|
US5314685A
(en)
|
1992-05-11 |
1994-05-24 |
Agouron Pharmaceuticals, Inc. |
Anhydrous formulations for administering lipophilic agents
|
US5711968A
(en)
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
JP2651320B2
(ja)
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
US5413672A
(en)
|
1992-07-22 |
1995-05-09 |
Ngk Insulators, Ltd. |
Method of etching sendust and method of pattern-etching sendust and chromium films
|
US5512293A
(en)
|
1992-07-23 |
1996-04-30 |
Alza Corporation |
Oral sustained release drug delivery device
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
GB9223146D0
(en)
|
1992-11-05 |
1992-12-16 |
Scherer Corp R P |
Vented capsule
|
DE69224386T2
(de)
|
1992-11-06 |
1998-06-18 |
Texas Instruments Inc |
Vorrichtung zum subkutanen Einführen einer Nadel
|
DK0669128T3
(da)
|
1992-11-17 |
2000-06-19 |
Yoshitomi Pharmaceutical |
Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme
|
USD342855S
(en)
|
1992-11-20 |
1994-01-04 |
Butler Ii George D |
Combined infant cushion and cover
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
SE9203594D0
(sv)
|
1992-11-30 |
1992-11-30 |
Christer Nystroem |
Laekemedel i dispersa system
|
EP1013270A3
(en)
|
1992-12-02 |
2001-03-28 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
RU2143889C1
(ru)
|
1993-02-23 |
2000-01-10 |
Генентек, Инк. |
Способ стабилизации полипептида, способы получения композиций полипептида и композиции
|
US5368588A
(en)
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
AU6410494A
(en)
|
1993-03-17 |
1994-10-11 |
Alza Corporation |
Device for the transdermal administration of alprazolam
|
US5514110A
(en)
|
1993-03-22 |
1996-05-07 |
Teh; Eutiquio L. |
Automatic flow control device
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
HU225496B1
(en)
|
1993-04-07 |
2007-01-29 |
Scios Inc |
Pharmaceutical compositions of prolonged delivery, containing peptides
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
US5639477A
(en)
|
1993-06-23 |
1997-06-17 |
Alza Corporation |
Ruminal drug delivery device
|
DE69401945T3
(de)
|
1993-06-25 |
2004-09-02 |
Alza Corp., Palo Alto |
Einarbeitung eines poly-n-vinylamids in ein transdermales system
|
WO1995001161A1
(en)
|
1993-06-29 |
1995-01-12 |
Leiras Oy |
Pack for use in, and method of hormonal replacement therapy
|
WO1995004752A1
(en)
|
1993-08-09 |
1995-02-16 |
Biomeasure, Inc. |
Therapeutic peptide derivatives
|
US5498255A
(en)
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
US5385887A
(en)
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
JP2700141B2
(ja)
|
1993-09-17 |
1998-01-19 |
富士化学工業株式会社 |
リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
|
AU679794B2
(en)
|
1993-09-29 |
1997-07-10 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutynin
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
ES2236700T3
(es)
|
1993-11-19 |
2005-07-16 |
Janssen Pharmaceutica N.V. |
1,2-benzazoles microencapsulados.
|
US5650173A
(en)
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
ES2172574T5
(es)
|
1993-11-19 |
2012-11-29 |
Alkermes, Inc. |
Preparación de micropartículas biodegradables que contienen un agente biológicamente activo
|
JPH07196479A
(ja)
|
1994-01-04 |
1995-08-01 |
Unitika Ltd |
マイクロカプセルの製造法
|
USD358644S
(en)
|
1994-01-18 |
1995-05-23 |
Bio Medic Data Systems, Inc. |
Transponder implanter
|
FR2715306B1
(fr)
|
1994-01-25 |
1996-03-15 |
Oreal |
Composition cosmétique ou dermopharmaceutique sous forme de pâte souple et procédé de préparation de ladite composition.
|
US6241734B1
(en)
|
1998-08-14 |
2001-06-05 |
Kyphon, Inc. |
Systems and methods for placing materials into bone
|
US5540665A
(en)
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
JP3203358B2
(ja)
|
1994-02-04 |
2001-08-27 |
リポコーア・ホールディング・アクチエボラーグ |
二重層製剤
|
US5697975A
(en)
|
1994-02-09 |
1997-12-16 |
The University Of Iowa Research Foundation |
Human cerebral cortex neural prosthetic for tinnitus
|
US5458888A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
US6007805A
(en)
|
1994-03-07 |
1999-12-28 |
Imperial College Of Science And Technology |
Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
|
ZA953078B
(en)
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
DE69431533T2
(de)
|
1994-06-13 |
2003-10-02 |
Alza Corp., Palo Alto |
Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
|
NL9401150A
(nl)
|
1994-07-12 |
1996-02-01 |
Nederland Ptt |
Werkwijze voor het aan een ontvangzijde aanbieden van een van een zendzijde afkomstig eerste aantal videosignalen, alsmede systeem, alsmede zender, alsmede netwerk, en alsmede ontvanger.
|
EP0804155B1
(en)
|
1994-07-13 |
2000-11-08 |
Alza Corporation |
Composition and method for enhancing transdermal electrotransport agent delivery
|
US5633011A
(en)
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
US5595759A
(en)
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
AU708529B2
(en)
|
1994-11-10 |
1999-08-05 |
University Of Kentucky Research Foundation, The |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
FR2730246B1
(fr)
|
1995-02-03 |
1997-03-21 |
Icbt Perfojet Sa |
Procede pour la fabrication d'une nappe textile non tissee par jets d'eau sous pression, et installation pour la mise en oeuvre de ce procede
|
FR2731150B1
(fr)
|
1995-03-03 |
1997-04-18 |
Oreal |
Utilisation de composes amphiphiles en tant qu'agent epaississant de milieux non aqueux
|
US5464929A
(en)
|
1995-03-06 |
1995-11-07 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
US6100346A
(en)
|
1995-03-06 |
2000-08-08 |
Ethicon, Inc. |
Copolymers of polyoxaamides
|
US5700583A
(en)
|
1995-03-06 |
1997-12-23 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters containing amines or amido groups
|
US6147168A
(en)
|
1995-03-06 |
2000-11-14 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters
|
US5597579A
(en)
|
1995-03-06 |
1997-01-28 |
Ethicon, Inc. |
Blends of absorbable polyoxaamides
|
US5595751A
(en)
|
1995-03-06 |
1997-01-21 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/or amido groups
|
US5618552A
(en)
|
1995-03-06 |
1997-04-08 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
US5698213A
(en)
|
1995-03-06 |
1997-12-16 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters
|
US5607687A
(en)
|
1995-03-06 |
1997-03-04 |
Ethicon, Inc. |
Polymer blends containing absorbable polyoxaesters
|
US5962023A
(en)
|
1995-03-06 |
1999-10-05 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
US6403655B1
(en)
|
1995-03-06 |
2002-06-11 |
Ethicon, Inc. |
Method of preventing adhesions with absorbable polyoxaesters
|
US5859150A
(en)
|
1995-03-06 |
1999-01-12 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters
|
US5844017A
(en)
|
1995-03-06 |
1998-12-01 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters containing amines and/or amido groups
|
US5648088A
(en)
|
1995-03-06 |
1997-07-15 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amide groups
|
IL113100A0
(en)
|
1995-03-23 |
1995-06-29 |
Schatz Anat |
Infant's mattress
|
US5542682A
(en)
|
1995-03-27 |
1996-08-06 |
American Variseal |
Slant coil spring and seal
|
US5736159A
(en)
|
1995-04-28 |
1998-04-07 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
|
EP0826376B1
(en)
|
1995-05-02 |
2007-01-24 |
Taisho Pharmaceutical Co. Ltd |
Composition for oral administration
|
US5939286A
(en)
|
1995-05-10 |
1999-08-17 |
University Of Florida |
Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
US5882676A
(en)
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US5718922A
(en)
|
1995-05-31 |
1998-02-17 |
Schepens Eye Research Institute, Inc. |
Intravitreal microsphere drug delivery and method of preparation
|
PT831826E
(pt)
|
1995-06-06 |
2003-02-28 |
Hoffmann La Roche |
Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
|
US5589187A
(en)
|
1995-06-07 |
1996-12-31 |
Wisconsin Alumni Research Foundation |
Protective encapsulation of micronutrients for ingestion by avian species
|
US6572879B1
(en)
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
UA48973C2
(ru)
|
1995-06-07 |
2002-09-16 |
Орто-Макнейл Фармасьютікалз Інк. |
Чрезкожный пластырь на основе 17-дезацетилированного норгестимата для предупреждения овуляции
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
US5690952A
(en)
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5782396A
(en)
|
1995-08-28 |
1998-07-21 |
United States Surgical Corporation |
Surgical stapler
|
US5906830A
(en)
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
US5655593A
(en)
|
1995-09-18 |
1997-08-12 |
Kaiser Aluminum & Chemical Corp. |
Method of manufacturing aluminum alloy sheet
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
GB9521125D0
(en)
|
1995-10-16 |
1995-12-20 |
Unilever Plc |
Cosmetic composition
|
SE505146C2
(sv)
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
GB9521805D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Solubilisation methods
|
ATE235505T1
(de)
|
1995-10-30 |
2003-04-15 |
Oleoyl Estrone Developments S |
Oleat monoester von estrogenen zur behandlung von fettleibigkeit
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
EP0858343B1
(en)
|
1995-11-02 |
2004-03-31 |
Schering Corporation |
Continuous low-dose cytokine infusion therapy
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
AUPN723395A0
(en)
|
1995-12-19 |
1996-01-18 |
Macnaught Medical Pty Limited |
Lubrication methods
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
DE69625623T2
(de)
|
1996-01-31 |
2003-11-06 |
Sumitomo Bakelite Co. Ltd., Tokio/Tokyo |
Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6156331A
(en)
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
WO1997028181A2
(en)
|
1996-02-02 |
1997-08-07 |
Rhomed Incorporated |
Post-labeling stabilization of radiolabeled proteins and peptides
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6132420A
(en)
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
PT877599E
(pt)
|
1996-02-02 |
2003-08-29 |
Alza Corp |
Administracao continua de leuprolido utilizando um sistema implantavel
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
DE69740176D1
(de)
|
1996-03-01 |
2011-05-26 |
Novo Nordisk As |
Appetithemmendes Peptid, Zusammensetzung und Verwendung
|
JPH09241153A
(ja)
|
1996-03-04 |
1997-09-16 |
Q P Corp |
静脈注射用脂肪乳剤
|
WO1997032883A1
(en)
|
1996-03-08 |
1997-09-12 |
Zeneca Limited |
Azolobenzazepine derivatives as neurologically active agents
|
CA2248538A1
(en)
|
1996-03-14 |
1997-09-18 |
The Immune Response Corporation |
Targeted delivery of genes encoding interferon
|
US5703200A
(en)
|
1996-03-15 |
1997-12-30 |
Ethicon, Inc. |
Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
|
DE69717263T2
(de)
|
1996-03-28 |
2003-07-24 |
Takeda Chemical Industries, Ltd. |
Zubereitung mit verzögerter freisetzung und deren herstellung
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
US6204022B1
(en)
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
US6074673A
(en)
|
1996-04-22 |
2000-06-13 |
Guillen; Manuel |
Slow-release, self-absorbing, drug delivery system
|
US5976109A
(en)
|
1996-04-30 |
1999-11-02 |
Medtronic, Inc. |
Apparatus for drug infusion implanted within a living body
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
TW487572B
(en)
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
EP0928136B1
(en)
|
1996-06-05 |
2003-10-22 |
Ashmont Holdings Limited |
Injectable compositions
|
ES2256888T3
(es)
|
1996-06-05 |
2006-07-16 |
Roche Diagnostics Gmbh |
Analogos de exendina, proceso para su preparacion y medicamentos que los contienen.
|
DE29610419U1
(de)
|
1996-06-14 |
1996-10-24 |
Filtertek, S.A., Plailly |
Schwerkraftinfusionsvorrichtung für medizinische Infusionen
|
GB9613858D0
(en)
|
1996-07-02 |
1996-09-04 |
Cortecs Ltd |
Hydrophobic preparations
|
AU737664B2
(en)
|
1996-07-03 |
2001-08-30 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
US5916582A
(en)
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
ES2259746T3
(es)
|
1996-07-15 |
2006-10-16 |
Alza Corporation |
Nuevas formulaciones para la administracion transdermica de fluoxetina.
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
PT966297E
(pt)
|
1996-08-08 |
2009-03-18 |
Amylin Pharmaceuticals Inc |
Regulação da motilidade gastrintestinal
|
AU3981097A
(en)
|
1996-08-21 |
1998-03-06 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release microparticles with a hydrophobic material
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US5984890A
(en)
|
1996-09-27 |
1999-11-16 |
American Home Products Corporation |
Medical device for the placement of solid materials
|
IN184589B
(ru)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
ES2191834T3
(es)
|
1996-10-24 |
2003-09-16 |
Alza Corp |
Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
|
US5817129A
(en)
|
1996-10-31 |
1998-10-06 |
Ethicon, Inc. |
Process and apparatus for coating surgical sutures
|
UA65549C2
(ru)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Применение аналогов и производных glp-1 для периферического введения для борьбы с ожирением
|
DE19646392A1
(de)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
US5928666A
(en)
|
1996-11-12 |
1999-07-27 |
Cygnus Inc. |
Crystalline form of estradiol and pharmaceutical formulations comprising same
|
PT1066081E
(pt)
|
1996-11-15 |
2003-12-31 |
Alza Corp |
Sistema de distribuicao osmotica e processo para melhorar o inicio e o desempenho de sistemas de distribuicao osmotica
|
GB9626513D0
(en)
|
1996-12-20 |
1997-02-05 |
Bioglan Ireland R & D Ltd |
A pharmaceutical composition
|
PT949905E
(pt)
|
1996-12-20 |
2001-12-28 |
Alza Corp |
Composicao de gel injectavel de efeito retardado e processo para a sua preparacao
|
DK1629849T4
(en)
|
1997-01-07 |
2017-12-04 |
Amylin Pharmaceuticals Llc |
Pharmaceutical compositions comprising exedins and agonists thereof
|
JP2001511128A
(ja)
|
1997-01-28 |
2001-08-07 |
ファルマシア・アンド・アップジョン・カンパニー |
水不溶性ポルフィリンの脂質錯体の凍結乾燥物
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
ZA981610B
(en)
|
1997-03-24 |
1999-08-26 |
Alza Corp |
Self adjustable exit port.
|
US5874388A
(en)
|
1997-04-02 |
1999-02-23 |
Dow Corning Corporation |
Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant
|
US6127520A
(en)
|
1997-04-15 |
2000-10-03 |
Regents Of The University Of Michigan |
Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles
|
JP2001524958A
(ja)
|
1997-04-17 |
2001-12-04 |
ジーエス ディベロップメント アクティエボラーグ |
新規な液晶をベースとする生物接着性薬剤送出系
|
MY118835A
(en)
|
1997-04-18 |
2005-01-31 |
Ipsen Pharma Biotech |
Sustained release compositions and the process for their preparation
|
BR9808697A
(pt)
|
1997-04-28 |
2000-07-11 |
Rhone Poulenc Rorer Sa |
Processo para inibir o crescimento de um tumor, vetor de adenovìrus defeituoso, vetor de vìrus, uso do mesmo, e, composição farmacêutica
|
US20020039594A1
(en)
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US6113947A
(en)
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
MY125849A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
MY125870A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
GB9718986D0
(en)
|
1997-09-09 |
1997-11-12 |
Danbiosyst Uk |
Controlled release microsphere delivery system
|
US6023802A
(en)
|
1997-09-10 |
2000-02-15 |
King; Susan Melton |
Infant sleeper
|
US6172046B1
(en)
|
1997-09-21 |
2001-01-09 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
ATE239447T1
(de)
|
1997-09-29 |
2003-05-15 |
Inhale Therapeutic Syst |
In verneblern verwendbare, stabilisierte zubereitungen
|
JPH11100353A
(ja)
|
1997-09-29 |
1999-04-13 |
Esupo Kk |
精製・脱臭液状エステルワックスとその組成物
|
US6133429A
(en)
|
1997-10-03 |
2000-10-17 |
Becton Dickinson And Company |
Chromophores useful for the preparation of novel tandem conjugates
|
USD399821S
(en)
|
1997-11-07 |
1998-10-20 |
Motorola, Inc. |
Front section of a battery charger
|
JP2001523688A
(ja)
|
1997-11-14 |
2001-11-27 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
新規エキセンジン・アゴニスト化合物
|
CA2311681A1
(en)
|
1997-12-08 |
1999-06-17 |
Genentech, Inc. |
Human interferon-epsilon: a type i interferon
|
US6368612B1
(en)
|
1997-12-12 |
2002-04-09 |
Biohybrid Technologies Llc |
Devices for cloaking transplanted cells
|
JP4215188B2
(ja)
|
1997-12-22 |
2009-01-28 |
インターシア セラピューティクス,インコーポレイティド |
薬剤供給を調節するデバイスのための速度調節膜
|
ATE289213T1
(de)
|
1997-12-29 |
2005-03-15 |
Alza Corp |
Kit zum implantieren eines implantats
|
EP1300174B1
(en)
|
1997-12-29 |
2005-02-16 |
Alza Corporation |
Implant insertion kit
|
AU1828599A
(en)
|
1997-12-29 |
1999-07-19 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
EP1041974B1
(en)
|
1997-12-30 |
2006-10-11 |
Alza Corporation |
Beneficial agent delivery system with membrane plug
|
US20040024068A1
(en)
|
1998-01-23 |
2004-02-05 |
Trustees Of Tufts College |
Antimicrobial compounds
|
IT1298575B1
(it)
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
|
US6017545A
(en)
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
ATE366115T1
(de)
|
1998-02-13 |
2007-07-15 |
Amylin Pharmaceuticals Inc |
Inotropische und diuretische effekte von exendin und glp-1
|
USD408917S
(en)
|
1998-02-26 |
1999-04-27 |
Minnesota Mining And Manufacturing Company |
Membrane support structure of a flow through cell for blood gas measurement
|
US6224577B1
(en)
|
1998-03-02 |
2001-05-01 |
Medrad, Inc. |
Syringes and plungers for use therein
|
US6056718A
(en)
|
1998-03-04 |
2000-05-02 |
Minimed Inc. |
Medication infusion set
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6183461B1
(en)
|
1998-03-11 |
2001-02-06 |
Situs Corporation |
Method for delivering a medication
|
US20020136848A1
(en)
|
1998-03-12 |
2002-09-26 |
Fumio Yoshii |
Lactone-containing resin composition, molded object thereof, and film
|
US6029361A
(en)
|
1998-03-25 |
2000-02-29 |
Ultratech Stepper, Inc. |
Air-guage nozzle probe structure for microlithographic image focusing
|
US6074660A
(en)
|
1998-04-20 |
2000-06-13 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/ or amido groups
|
TW586944B
(en)
|
1998-05-29 |
2004-05-11 |
Sumitomo Pharma |
Controlled release agent having a multi-layer structure
|
US8626302B2
(en)
|
1998-06-03 |
2014-01-07 |
Spr Therapeutics, Llc |
Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
|
WO1999064061A1
(en)
|
1998-06-12 |
1999-12-16 |
Bionebraska, Inc. |
GLUCAGON-LIKE PEPTIDE-1 IMPROVES β-CELL RESPONSE TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
|
ES2325141T3
(es)
|
1998-07-17 |
2009-08-26 |
Pacira Pharmaceuticals, Inc. |
Composiciones biodegradables para la liberacion controlada de sustancias encapsuladas.
|
US7390637B2
(en)
|
1998-07-21 |
2008-06-24 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
US6472512B1
(en)
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
US6270700B1
(en)
|
1998-07-23 |
2001-08-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Encapsulation of water soluble peptides
|
USD415073S
(en)
|
1998-08-17 |
1999-10-12 |
ScooterBug, Inc. |
Stroller
|
US6720407B1
(en)
|
1998-08-28 |
2004-04-13 |
Eli Lilly And Company |
Method for administering insulinotropic peptides
|
US6551613B1
(en)
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
DE69928815T2
(de)
|
1998-09-09 |
2006-06-29 |
Alza Corp., Mountain View |
Dosierungsform mit flüssiger formulierung
|
US6174547B1
(en)
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
US6248112B1
(en)
|
1998-09-30 |
2001-06-19 |
C. R. Bard, Inc. |
Implant delivery system
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
JP2002528486A
(ja)
|
1998-11-02 |
2002-09-03 |
アルザ・コーポレーション |
有効物質の送達制御
|
AU1623300A
(en)
|
1998-11-13 |
2000-06-05 |
Sensor Technologies, Inc. |
Monodisperse preparations useful with implanted devices
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
CZ295890B6
(cs)
|
1998-12-07 |
2005-11-16 |
Societe De Conseils De Recherches Et D'application |
Analogy GLP-1, mající kyselinu aminoizomáselnou pozici 8 a D-arginin na pozici 36, jejich použití a farmaceutické prostředky je obsahující
|
CA2354472C
(en)
|
1998-12-17 |
2009-02-24 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
ATE251448T1
(de)
|
1998-12-23 |
2003-10-15 |
Amgen Inc |
Polyol/öl-suspensionen zur verzörgerten freisetzung von proteinen
|
WO2000039280A2
(en)
|
1998-12-31 |
2000-07-06 |
Viragen, Inc. |
Leukocyte-derived interferon preparations
|
US6433144B1
(en)
|
1999-01-12 |
2002-08-13 |
Viragen, Inc. |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
|
DE69906132T2
(de)
|
1998-12-31 |
2003-12-18 |
Alza Corp., Mountain View |
Osmotisches verabreichungsystem mit raumsparenden kolben
|
WO2000040273A2
(en)
|
1999-01-08 |
2000-07-13 |
Vical Incorporated |
Treatment of viral diseases using an interferon omega expressing polynucleotide
|
US6703225B1
(en)
|
1999-01-12 |
2004-03-09 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α
|
US7399489B2
(en)
|
1999-01-14 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Exendin analog formulations
|
ES2343072T3
(es)
|
1999-01-14 |
2010-07-22 |
Amylin Pharmaceuticals, Inc. |
Exendina para la supresion del glucagon.
|
DE60021166T3
(de)
|
1999-01-14 |
2019-08-22 |
Amylin Pharmaceuticals, Llc |
Neue exendin agonist formulierungen und deren verabreichung
|
PT1666026E
(pt)
|
1999-02-08 |
2012-03-15 |
Intarcia Therapeutics Inc |
Veículos viscosos não aquosos biocompatíveis monofásicos e métodos para a preparação dos mesmos
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
US6451974B1
(en)
|
1999-03-17 |
2002-09-17 |
Novo Nordisk A/S |
Method of acylating peptides and novel acylating agents
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US6541021B1
(en)
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
JP2002540850A
(ja)
|
1999-04-05 |
2002-12-03 |
ファーマシューティカル ディスカバリー コーポレイション |
微粉形成のための方法
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
CN1355708A
(zh)
|
1999-04-19 |
2002-06-26 |
先灵公司 |
包含利巴韦林与抗氧化剂的hcv联合治疗
|
US6924264B1
(en)
|
1999-04-30 |
2005-08-02 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
WO2000067728A2
(de)
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
US6514500B1
(en)
|
1999-10-15 |
2003-02-04 |
Conjuchem, Inc. |
Long lasting synthetic glucagon like peptide {GLP-!}
|
ES2209885T3
(es)
|
1999-05-17 |
2004-07-01 |
Conjuchem, Inc. |
Peptidos insulinotropicos de larga duracion.
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
CN100370967C
(zh)
|
1999-06-04 |
2008-02-27 |
阿尔萨公司 |
埋植凝胶组合物及其制备方法
|
US20030059376A1
(en)
|
1999-06-04 |
2003-03-27 |
Libbey Miles A. |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
EP1187639A1
(en)
|
1999-06-04 |
2002-03-20 |
Delrx Pharmaceutical Corporation |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
US20010040326A1
(en)
|
1999-06-14 |
2001-11-15 |
Lord Corporation |
Resilient member with deformed element and method of forming same
|
US6833256B1
(en)
|
1999-06-22 |
2004-12-21 |
University Of Maryland |
Interferon tau mutants and methods for making them
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
USD445975S1
(en)
|
1999-08-27 |
2001-07-31 |
Black & Decker, Inc. |
Base unit for a hand held vacuum cleaner
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
MXPA02003733A
(es)
|
1999-10-15 |
2003-10-14 |
Advanced Cell Tech Inc |
Metodos para producir celulas progenitoras diferenciadas y celulas troncales embrionicas de lineas de descendencia defectivas.
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
US6436091B1
(en)
|
1999-11-16 |
2002-08-20 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
WO2001043528A2
(en)
|
1999-12-17 |
2001-06-21 |
Durect Corporation |
Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide
|
DE60023361T2
(de)
|
1999-12-21 |
2006-04-27 |
Alza Corp., Mountain View |
Ventil für osmotische vorrichtungen
|
US6498193B2
(en)
|
1999-12-22 |
2002-12-24 |
Trustees Of Dartmouth College |
Treatment for complications of type 2 diabetes
|
US6283949B1
(en)
|
1999-12-27 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Refillable implantable drug delivery pump
|
US6572890B2
(en)
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
US6472060B1
(en)
|
2000-01-19 |
2002-10-29 |
Seco Tools Ab |
Coated body with nanocrystalline CVD coating for enhanced edge toughness and reduced friction
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
US6471688B1
(en)
|
2000-02-15 |
2002-10-29 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
EP1267912A2
(en)
|
2000-03-14 |
2003-01-02 |
Burkhard Göke |
Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
|
US20030211974A1
(en)
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
TWI250874B
(en)
|
2000-03-24 |
2006-03-11 |
Nat Health Research Institutes |
Pharmaceutical compositions for preventing or treating disorders associated with bacterial or viral infection
|
EP1274459B1
(en)
|
2000-04-19 |
2005-11-16 |
Genentech, Inc. |
Sustained release formulations comprising growth hormone
|
EP1278551A2
(en)
|
2000-04-21 |
2003-01-29 |
Vical Incorporated |
Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
|
AU2001263230B2
(en)
|
2000-05-19 |
2005-03-10 |
Amylin Pharmaceuticals, Llc |
Treatment of acute coronary syndrome with glp-1
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
DK1695983T3
(da)
|
2000-06-16 |
2009-05-18 |
Lilly Co Eli |
Glucagon-lignende peptid-1 analoger
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6547250B1
(en)
|
2000-08-21 |
2003-04-15 |
Westport Research Inc. |
Seal assembly with two sealing mechanisms for providing static and dynamic sealing
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
CA2423431A1
(en)
|
2000-10-06 |
2002-04-11 |
Durect Corporation |
Devices and methods for management of inflammation
|
KR20040007413A
(ko)
|
2000-11-03 |
2004-01-24 |
바이오메디신즈 인코포레이티드 |
단기 및 장기 약물 약량측정 방법
|
EP1335704A2
(en)
|
2000-11-16 |
2003-08-20 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
US20050070883A1
(en)
|
2000-11-29 |
2005-03-31 |
Brown James E |
Devices and methods for controlled delivery from a drug delivery device
|
US20020165286A1
(en)
|
2000-12-08 |
2002-11-07 |
Hanne Hedeman |
Dermal anti-inflammatory composition
|
WO2002047716A2
(en)
|
2000-12-13 |
2002-06-20 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
AU2002228608A1
(en)
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
RU2275207C2
(ru)
|
2000-12-14 |
2006-04-27 |
Амилин Фармасьютикалз, Инк. |
Способ снижения доступности питательного вещества, способ подавления аппетита
|
AU2002232824A1
(en)
|
2000-12-21 |
2002-07-01 |
Inhale Therapeutic Systems, Inc. |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
USD472896S1
(en)
|
2000-12-23 |
2003-04-08 |
Andreas Peiker |
Telephone support
|
IN188924B
(ru)
|
2001-03-01 |
2002-11-23 |
Bharat Serums & Vaccines Ltd |
|
EP1379197A4
(en)
|
2001-03-23 |
2009-06-03 |
Durect Corp |
DISPOSAL OF MEDICINAL PRODUCTS OF DELAYED RELEASE DEVICES IMPLANTED IN MYOKARD TISSUE OR PER ICARDROOM
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
JP2005506956A
(ja)
|
2001-06-01 |
2005-03-10 |
イーライ・リリー・アンド・カンパニー |
長時間作用性glp−1製剤
|
US6514517B2
(en)
|
2001-06-20 |
2003-02-04 |
Ethicon, Inc. |
Antimicrobial coatings for medical devices
|
US7318931B2
(en)
|
2001-06-21 |
2008-01-15 |
Genentech, Inc. |
Sustained release formulation
|
ATE478656T1
(de)
|
2001-06-22 |
2010-09-15 |
Univ Johns Hopkins Med |
Biologisch abbaubare polymerzusammensetzungen, zusammensetzungen und damit in beziehung stehende verwendungen
|
EP1401503B1
(en)
|
2001-06-22 |
2007-05-09 |
Pfizer Products Inc. |
Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer
|
US7163688B2
(en)
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
US20030138403A1
(en)
|
2001-06-29 |
2003-07-24 |
Maxygen Aps |
Interferon formulations
|
IL159784A0
(en)
|
2001-07-20 |
2004-06-20 |
Intermune Inc |
Methods of treating liver fibrosis
|
US7576050B2
(en)
|
2001-07-31 |
2009-08-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
GLP-1 exendin-4 peptide analogs and uses thereof
|
MXPA04001525A
(es)
|
2001-08-23 |
2004-05-31 |
Lilly Co Eli |
Analogos de peptido -1 similar al glucagon.
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
US20030064095A1
(en)
|
2001-09-14 |
2003-04-03 |
Imedd, Inc. |
Microfabricated nanopore device for sustained release of therapeutic agent
|
EP1435919B1
(en)
|
2001-09-17 |
2009-09-23 |
Durect Corporation |
Device and method for accurate delivery of an active agent
|
AU2002332054B2
(en)
|
2001-09-24 |
2007-11-08 |
Imperial Innovations Limited |
Modification of feeding behavior
|
KR20050030886A
(ko)
|
2001-10-05 |
2005-03-31 |
인터뮨, 인크. |
다단계 인터페론 전달 프로필로 간염 바이러스 감염의 치료 방법
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
WO2003034960A1
(en)
|
2001-10-24 |
2003-05-01 |
Med-El Elektromedizinische Geräte Ges.m.b.H. |
Implantable fluid delivery apparatuses and implantable electrode
|
US20040142902A1
(en)
|
2001-11-08 |
2004-07-22 |
Struijker- Boudier Harry A.J. |
Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
|
CN100438870C
(zh)
|
2001-11-09 |
2008-12-03 |
精达制药公司 |
ω干扰素在制备治疗温血动物对象中病毒性疾病的药物中的用途
|
NZ533436A
(en)
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Catheter injectable depot compositons and uses thereof
|
ATE507816T1
(de)
|
2001-11-14 |
2011-05-15 |
Durect Corp |
Injizierbare depotzusammensetzungen und deren verwendung
|
WO2003041685A1
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Injectable depot composition
|
DE10159217A1
(de)
|
2001-11-27 |
2003-06-05 |
Schering Ag |
17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
|
US20030108608A1
(en)
|
2001-12-12 |
2003-06-12 |
Erik Laridon |
Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver
|
US20030232078A1
(en)
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
ES2500918T3
(es)
|
2001-12-21 |
2014-10-01 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina e interferón beta
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
US7105489B2
(en)
|
2002-01-22 |
2006-09-12 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for treating polycystic ovary syndrome
|
WO2003066585A2
(en)
|
2002-02-08 |
2003-08-14 |
Alkermes Controlled Therapeutics, Inc. |
Polymer-based compositions for sustained release
|
CA2476589C
(en)
|
2002-02-27 |
2014-02-25 |
Pharmain, Ltd. |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
GB0204722D0
(en)
|
2002-02-28 |
2002-04-17 |
Norferm Da |
Method
|
GB2386066A
(en)
|
2002-02-28 |
2003-09-10 |
Norbrook Lab Ltd |
Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
|
US7258873B2
(en)
|
2002-04-11 |
2007-08-21 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by spray drying
|
PT2561860T
(pt)
|
2002-05-31 |
2018-05-08 |
Titan Pharmaceuticals Inc |
Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
|
CA2489325C
(en)
|
2002-06-17 |
2010-08-10 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
KR101046903B1
(ko)
|
2002-06-26 |
2011-07-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 약물 전달 시스템을 위한, 최소로 튀는 용적효율성 피스톤
|
US7177526B2
(en)
|
2002-06-28 |
2007-02-13 |
Intel Corporation |
System and method for improving audio during post-production of video recordings
|
CN1684663A
(zh)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
AU2002359397B2
(en)
|
2002-07-31 |
2009-01-29 |
Durect Corporation |
Injectable depot compositions and uses thereof
|
US20080260838A1
(en)
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
US20060084922A1
(en)
|
2002-09-04 |
2006-04-20 |
Ruark Botha |
Device for securing a blood vessel cannula to a body
|
US20040121009A1
(en)
|
2002-10-17 |
2004-06-24 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US7462365B2
(en)
|
2002-10-17 |
2008-12-09 |
Costantino Henry R |
Microencapsulation and sustained release of biologically active polypeptides
|
ES2320754T3
(es)
|
2002-10-22 |
2009-05-28 |
Waratah Pharmaceuticals, Inc. |
Tratamiento de la diabetes.
|
JP2006508127A
(ja)
|
2002-11-06 |
2006-03-09 |
アルザ・コーポレーション |
制御された放出性デポー剤配合物
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
US7014636B2
(en)
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
US7790681B2
(en)
|
2002-12-17 |
2010-09-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
JP2006512370A
(ja)
|
2002-12-19 |
2006-04-13 |
アルザ・コーポレーション |
安定な非水性単相ゲル、および植込み型デバイスから送達するためのその配合物
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
JP2004238392A
(ja)
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
安定化された蛋白質性製剤
|
US7507114B2
(en)
|
2003-02-18 |
2009-03-24 |
Medconx, Inc. |
Male medical device electrical connector with engineered friction fit
|
MXPA05010604A
(es)
|
2003-03-31 |
2005-11-23 |
Alza Corp |
Sistema de administracion osmotica y metodo para disminuir los tiempos de arranque para sistemas de administracion osmotica.
|
JP2006521897A
(ja)
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
内部圧力を放散する手段を備える浸透ポンプ
|
TW200505500A
(en)
|
2003-03-31 |
2005-02-16 |
Alza Corp |
Non-aqueous single phase vehicles and formulations utilizing such vehicles
|
JP2007504920A
(ja)
|
2003-05-16 |
2007-03-08 |
ブルー メンブレーンス ゲーエムベーハー |
生体適合性コーティングされた医療用インプラント
|
WO2004103342A2
(en)
|
2003-05-16 |
2004-12-02 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
US20050079202A1
(en)
|
2003-05-30 |
2005-04-14 |
Guohua Chen |
Implantable elastomeric depot compositions and uses thereof
|
WO2005000222A2
(en)
|
2003-05-30 |
2005-01-06 |
Amylin Pharmaceuticals, Inc. |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
CN102940879B
(zh)
|
2003-06-03 |
2017-06-06 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
US8491571B2
(en)
|
2003-06-12 |
2013-07-23 |
Cordis Corporation |
Orifice device having multiple channels with varying flow rates for drug delivery
|
US7454765B2
(en)
|
2003-07-09 |
2008-11-18 |
Samsung Electronics Co., Ltd. |
Optical disc drive
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
CN1859900A
(zh)
|
2003-09-30 |
2006-11-08 |
阿尔萨公司 |
具有递增释放特征的渗透压驱动的活性剂输送装置
|
US9005244B2
(en)
|
2003-09-30 |
2015-04-14 |
Ethicon, Inc. |
Tissue approximation device
|
RU2006118808A
(ru)
|
2003-10-31 |
2007-12-10 |
Алза Корпорейшн (Us) |
Осмотический насос с самоудерживающейся, выполненной с возможностью быстрого пуска мембранной пробкой
|
RU2006119632A
(ru)
|
2003-11-06 |
2007-12-20 |
Алза Корпорейшн (Us) |
Модульный ограничитель скорости впитывания для использования с имплантируемым осмотическим насосом
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US7780973B2
(en)
|
2003-12-15 |
2010-08-24 |
Ethicon Endo-Surgery, Inc. |
Method and device for minimally invasive implantation of biomaterial
|
US20050216087A1
(en)
|
2004-01-05 |
2005-09-29 |
St. Francis Medical Technologies, Inc. |
Disk repair structures for positioning disk repair material
|
US20050175701A1
(en)
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
BRPI0507594A
(pt)
|
2004-02-11 |
2007-07-03 |
Amylin Pharmaceuticals Inc |
polipetìdeos hìbridos com propriedades selecionáveis
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
CN1968700A
(zh)
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
WO2005112977A2
(en)
|
2004-04-23 |
2005-12-01 |
Pharmain, Ltd. |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
US20050266087A1
(en)
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
US20090042781A1
(en)
|
2004-06-28 |
2009-02-12 |
Novo Nordisk A/S |
Methods for Treating Diabetes
|
US7772182B2
(en)
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
DE112005001978B4
(de)
|
2004-08-18 |
2014-01-16 |
Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) |
Definierter Leckagepfad für Hochdruckdichtung
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
US20060094693A1
(en)
|
2004-09-21 |
2006-05-04 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
MX366832B
(es)
|
2004-10-01 |
2019-07-24 |
Ramscor Inc |
Composiciones de farmaco de liberacion sostenida convenientemente implantables.
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
ATE427759T1
(de)
|
2004-11-01 |
2009-04-15 |
Amylin Pharmaceuticals Inc |
Behandlung von fettsucht und verbundenen erkrankungen
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
US7575579B2
(en)
|
2004-11-18 |
2009-08-18 |
Union Surgical, Llc |
Drill guide tissue protector
|
US20060141040A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060142234A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
EP1841448A2
(en)
|
2004-12-30 |
2007-10-10 |
Diakine Therapeutics, Inc. |
Pharmaceutical compositions and methods for restoring beta-cell mass and function
|
USD587374S1
(en)
|
2005-01-14 |
2009-02-24 |
Edwards Lifesciences Corporation |
Sensor case
|
EP1841492B1
(en)
|
2005-01-24 |
2016-08-10 |
Merck Sharp & Dohme B.V. |
Applicator for inserting an implant
|
WO2006081279A2
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US20060216242A1
(en)
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
EP2361630A1
(en)
|
2005-02-03 |
2011-08-31 |
Intarcia Therapeutics, Inc |
Implantable drug delivery device comprising particles and an osmotic pump
|
US20070032420A1
(en)
|
2005-02-09 |
2007-02-08 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
BRPI0606992A2
(pt)
|
2005-02-11 |
2009-07-28 |
Amylin Pharmaceuticals Inc |
análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
KR101383493B1
(ko)
|
2005-03-31 |
2014-04-11 |
아스트라제네카 파마수티컬스 엘피 |
정신의학적 질환 및 장애를 치료하기 위한 아밀린 및아밀린 효능제
|
US20080200383A1
(en)
|
2005-04-08 |
2008-08-21 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
|
EP1874339A1
(en)
|
2005-04-21 |
2008-01-09 |
Gastrotech Pharma A/S |
Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
|
US7569050B2
(en)
|
2005-05-06 |
2009-08-04 |
Medtronic Minimed, Inc. |
Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion
|
JP5198261B2
(ja)
|
2005-06-06 |
2013-05-15 |
カムルス エービー |
Glp−1類似体製剤
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
WO2007013957A2
(en)
|
2005-07-22 |
2007-02-01 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
EP2330124B1
(en)
|
2005-08-11 |
2015-02-25 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
RU2421237C2
(ru)
|
2005-08-19 |
2011-06-20 |
Амилин Фармасьютикалз, Инк. |
Способы лечения диабета и снижения массы тела
|
EP1965823B1
(en)
|
2005-11-04 |
2016-05-18 |
Glaxosmithkline LLC |
Methods for administering hypoglycemic agents
|
WO2007053946A1
(en)
|
2005-11-09 |
2007-05-18 |
Conjuchem Biotechnologies Inc. |
Method of treating diabetes and/or obesity with reduced nausea side effects using an insulinotropic peptide conjugated to albumin
|
US20090209460A1
(en)
|
2005-12-16 |
2009-08-20 |
Amylin Pharmaceuticals, Inc. |
Compositions and methods for treating obesity and related metabolic disorders
|
WO2007075534A2
(en)
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
ES2397712T3
(es)
|
2006-01-18 |
2013-03-08 |
Qps, Llc |
Composiciones farmacéuticas con estabilidad reforzada
|
CA2646598C
(en)
|
2006-03-21 |
2014-08-19 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of using same
|
BRPI0711119A2
(pt)
|
2006-05-02 |
2011-08-30 |
Actogenix Nv |
administração microbiana de peptìdeos intestinais associados à obesidade
|
EP2029160A2
(en)
|
2006-05-12 |
2009-03-04 |
Amylin Pharmaceuticals, Inc. |
Methods to restore glycemic control
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
MX2009000434A
(es)
|
2006-07-11 |
2009-01-29 |
Qps Llc |
Composiciones farmaceuticas para la distribucion de liberacion sostenida de peptidos.
|
US8501693B2
(en)
|
2006-08-04 |
2013-08-06 |
Amylin Pharmaceuticals, Llc |
Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
WO2008041246A2
(en)
|
2006-10-05 |
2008-04-10 |
Panacea Biotec Ltd. |
Injectable depot composition and its' process of preparation
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
USD555589S1
(en)
|
2007-01-23 |
2007-11-20 |
Intec, Inc. |
Battery charger and game controller cradle
|
WO2008092084A2
(en)
|
2007-01-26 |
2008-07-31 |
Centocor, Inc. |
Injectable non-aqueous suspension with high concentration of therapeutic agent
|
EP1958576A3
(en)
|
2007-02-13 |
2009-08-05 |
Arthrex Inc |
Double cut shaver
|
US8262667B1
(en)
|
2007-02-23 |
2012-09-11 |
Holmed Corporation |
Multi-diameter implant forceps
|
RU2440097C2
(ru)
|
2007-04-23 |
2012-01-20 |
Интарсия Терапьютикс, Инк. |
Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
|
WO2008134425A1
(en)
|
2007-04-27 |
2008-11-06 |
Cedars-Sinai Medical Center |
Use of glp-1 receptor agonists for the treatment of gastrointestinal disorders
|
CN102231981A
(zh)
|
2008-02-08 |
2011-11-02 |
昌达生物科技公司 |
蛋白质或肽的缓释给药组合物
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
AU2009214632B2
(en)
|
2008-02-14 |
2015-02-19 |
Reshape Lifesciences, Inc. |
Treatment of excess weight by neural downregulation in combination with compositions
|
WO2009109921A1
(en)
|
2008-03-05 |
2009-09-11 |
Grant Pierre Van Antwerp |
A clamp device
|
WO2009109927A2
(en)
|
2008-03-05 |
2009-09-11 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
|
US20090234392A1
(en)
|
2008-03-13 |
2009-09-17 |
Depuy Spine, Inc. |
Method for inserting a spinal fixation element using implants having guide tabs
|
DK2268299T3
(da)
|
2008-04-01 |
2013-10-07 |
Mosamedix Bv |
Sammensætninger til reduktion af ardannelse under sårheling
|
US8483830B2
(en)
|
2008-04-04 |
2013-07-09 |
Enteromedics Inc. |
Methods and systems for glucose regulation
|
US20110263496A1
(en)
|
2008-05-21 |
2011-10-27 |
Amylin Pharmaceuticals, Inc. |
Exendins to lower cholesterol and triglycerides
|
JP5753779B2
(ja)
*
|
2008-06-17 |
2015-07-22 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
生理学的pHの緩衝液中で向上した溶解性及び安定性を示すグルカゴン類縁体
|
NZ591810A
(en)
|
2008-09-17 |
2012-12-21 |
Chiasma Inc |
Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
|
CN102202646A
(zh)
|
2008-09-30 |
2011-09-28 |
Endo药物方法有限公司 |
用于输送利培酮的可植入装置及其使用方法
|
NZ592113A
(en)
|
2008-10-15 |
2012-04-27 |
Intarcia Therapeutics Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
WO2010068467A1
(en)
|
2008-11-25 |
2010-06-17 |
Attenuex Technologies, Inc. |
Implant with high vapor pressure medium
|
US20100298840A1
(en)
|
2009-05-22 |
2010-11-25 |
Schwartz Lyman D |
Phimosis Treatment Device and Method
|
SG176858A1
(en)
*
|
2009-06-16 |
2012-02-28 |
Univ Indiana Res & Tech Corp |
Gip receptor-active glucagon compounds
|
USD638478S1
(en)
|
2009-07-06 |
2011-05-24 |
Performance Designed Products Llc |
Video game controller accessory
|
US20110022165A1
(en)
|
2009-07-23 |
2011-01-27 |
Edwards Lifesciences Corporation |
Introducer for prosthetic heart valve
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
USD789539S1
(en)
|
2015-07-09 |
2017-06-13 |
Spinal Surgical Strategies, Llc |
Fusion cage
|
EP3735944A1
(en)
|
2009-09-28 |
2020-11-11 |
Intarcia Therapeutics, Inc. |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
CN104311657B
(zh)
|
2009-12-16 |
2020-12-08 |
诺沃—诺迪斯克有限公司 |
双酰化glp-1衍生物
|
AR079345A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
WO2011156407A2
(en)
|
2010-06-09 |
2011-12-15 |
Amylin Pharmaceuticals, Inc. |
Glp-1 receptor agonists to treat pancre-atitis
|
USD669589S1
(en)
|
2010-08-31 |
2012-10-23 |
Koninklijke Philips Electronics N.V. |
Blood system cartridge
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
EP3434687B1
(en)
*
|
2011-06-10 |
2021-03-10 |
Hanmi Science Co., Ltd. |
Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
|
EP2729493B1
(en)
|
2011-07-04 |
2020-06-10 |
IP2IPO Innovations Limited |
Novel compounds and their effects on feeding behaviour
|
WO2013040550A1
(en)
|
2011-09-16 |
2013-03-21 |
Golden Aluminum Company |
Application of designs to portion of food container
|
TWD149032S
(zh)
|
2011-10-04 |
2012-09-01 |
虹光精密工業股份有限公司 |
手持式掃描器底座
|
EP2578599A1
(en)
*
|
2011-10-07 |
2013-04-10 |
LanthioPep B.V. |
Cyclic analogs of GLP-1 and GLP-1 related peptides
|
MX2014003579A
(es)
|
2011-11-17 |
2015-04-10 |
Univ Indiana Res & Tech Corp |
Peptidos de la superfamilia de glucagon que presentan actividad del receptor de glucocorticoide.
|
DK2838446T3
(en)
|
2012-04-19 |
2019-01-07 |
Removaid As |
DEVICE FOR REMOVING AN OBJECT IMPLANTED UNDER THE SKIN
|
CA2874401A1
(en)
|
2012-05-29 |
2013-12-05 |
National University Corporation Kochi University |
Artery visualization device and artery imaging device
|
US20140058425A1
(en)
|
2012-08-27 |
2014-02-27 |
Amir Porat |
Manually operated surgical devices with operative portions formed of a see-through material
|
US9332995B2
(en)
|
2012-09-25 |
2016-05-10 |
Russo Inventions, Llc |
Bone-harvesting tool
|
US9241722B2
(en)
|
2012-10-08 |
2016-01-26 |
Warsaw Orthopedic, Inc. |
Surgical pin guide and methods of use
|
EP2919764A1
(en)
|
2012-11-19 |
2015-09-23 |
Braeburn Pharmaceuticals BVBA SPRL |
Implantable drug delivery compositions and methods of treatment thereof
|
CN105324125A
(zh)
|
2013-03-15 |
2016-02-10 |
印第安纳大学研究及科技有限公司 |
具有长效的前体药物
|
USD731630S1
(en)
|
2014-04-08 |
2015-06-09 |
Bootz Manufacturing Company |
Shower pan
|
JP6217521B2
(ja)
|
2014-05-21 |
2017-10-25 |
トヨタ自動車株式会社 |
燃料電池システム及びその制御方法
|
USD724740S1
(en)
|
2014-06-05 |
2015-03-17 |
Deka Products Limited Partnership |
Enclosure for a peritoneal dialysis device
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
USD769540S1
(en)
|
2015-03-19 |
2016-10-18 |
Safer Sports Technologies |
Protective head guard insert
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
USD789540S1
(en)
|
2016-01-29 |
2017-06-13 |
Veterinary Implants Direct, Llc. |
Orthopedic plate
|
JP6594797B2
(ja)
|
2016-02-26 |
2019-10-23 |
エイブリック株式会社 |
スイッチングレギュレータ
|
US9931133B2
(en)
|
2016-03-24 |
2018-04-03 |
A.M. Surgical, Inc. |
Compact endoscopic surgical device and method of use thereof
|
WO2017200943A1
(en)
*
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
IL267736B2
(en)
|
2017-01-03 |
2024-03-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|